01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

(No title) October 21, 2020 – Posted in: Tiziana Life Sciences (TILS)

21st October, 2020 Tiziana Life Sciences Plc (“Tiziana” or the “Company”) Exercise of options, Issue of Equity PDMR Dealing and Total Voting Rights Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued total of 1,750,000 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid; (i) in…

Continue reading

Tiziana Life Sciences – Issue of Equity on Exercise of Warrants October 20, 2020 – Posted in: Tiziana Life Sciences (TILS)

20th October, 2020 Tiziana Life Sciences Plc (“Tiziana” or the “Company”) Issue of Equity on Exercise of Warrants Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and issued 35,714 ordinary shares of 3 pence each (“New Ordinary Shares”) credited as fully paid at a price of 70 pence per share in…

Continue reading

Tiziana Life Sciences – Patent Granted August 24, 2020 – Posted in: Tiziana Life Sciences (TILS)

  24th August, 2020 Tiziana Life Sciences plc  (“Tiziana” or the “Company”) Tiziana Granted a Patent on Methods and Use of Anti-IL-6/IL-6 receptor Monoclonal Antibodies as Prophylactic and Therapeutic Interventions for Covid-19 and other pulmonary diseases Tiziana Life Sciences plc (Nasdaq: TLSA; AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announces that the United States Patent and Trademark Office (“USPTO”) has granted a patent…

Continue reading

Tiziana Life Sciences Plc – Exercise of Warrants and Issue of Equity and Total Voting Rights June 3, 2020 – Posted in: Tiziana Life Sciences (TILS)

Tiziana Life Sciences plc (“Tiziana” or the “Company”) Correction – Exercise of Warrants and Issue of Equity and Total Voting Rights The announcement (RNS Number: 6069O) released on 2 June 2020 at 07:00 am stated that 1,498,685 new ordinary shares will be issued yielding £710,843 in cash proceeds, the announcement should have stated the number of shares to be issued is 1,234,399, yielding £578,700 cash proceeds. All other details in the announcement remain unchanged. The amended announcement is set out below:…

Continue reading

Tiziana Life Sciences – TR1 Notification – Quilter Plc May 21, 2020 – Posted in: Tiziana Life Sciences (TILS)

TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:                    Tiziana Life Sciences Plc 1b. Please indicate if the issuer is a non-UK issuer  (please mark with an…

Continue reading

The Appliance of Life Science Looks Exciting for this On-the-Nose Medical Explorer. September 11, 2019 – Posted in: Tiziana Life Sciences (TILS)

by Malcolm Stacey Hello, Share Troopers. Previously, I’ve written on the huge potential of life science companies which explore antibodies and antibody substitutes in the fight against serious conditions like cancer. Allow me to put another such firm before you. Tiziana Life Sciences plc (TILS) is biotechnology outfit which uses antibodies to find new treatments for inflammatory diseases and cancers. The company has just announced good news which sent the share price alight this week.…

Continue reading